Karyopharm Therapeutics:预计2025年第三季度总收入及美国Xpovio净产品收入分别为4200万至4400万美元和约3200万美元

美股速递
Oct 08, 2025

Karyopharm Therapeutics公布,预计2025年第三季度总收入将在4200万美元至4400万美元区间内,美国Xpovio净产品收入预计约为3200万美元。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10